Supernus Pharmaceuticals Inc (SUPN)
Equity Ratio
72.21%
Quarterly · Period ending:
SUPN Equity Ratio
Latest reported72.21%period ending
Latest reported72.21%period ending
SUPN Quarterly Equity Ratio (-7.70% → 72.21%)
Latest values, visible window
High-resolution chart · PNG
SUPN equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 72.2092% | |
| 71.7523% | |
| 73.0882% | |
| 73.933% | |
| 76.9601% | |
| 76.5021% | |
| 75.7074% | |
| 75.0093% | |
| 72.7643% | |
| 71.2501% | |
| 72.1246% | |
| 70.9788% | |
| 71.1398% | |
| 50.9067% | |
| 52.0529% | |
| 50.3682% | |
| 49.6429% | |
| 50.5299% | |
| 48.2994% | |
| 52.1188% | |
| 49.9395% | |
| 50.0479% | |
| 49.5218% | |
| 46.9449% | |
| 44.6657% | |
| 51.5506% | |
| 51.3175% | |
| 50.3435% | |
| 49.1601% | |
| 46.8106% | |
| 46.3303% | |
| 45.7377% | |
| 45.7895% | |
| 42.6425% | |
| 63.0159% | |
| 65.286% | |
| 66.2289% | |
| 63.9442% | |
| 61.9428% | |
| 60.8072% | |
| 64.5017% | |
| 65.89% | |
| 62.9868% | |
| 65.6209% | |
| 66.3983% | |
| 67.7356% | |
| 51.8908% | |
| 52.3404% | |
| 35.4273% | |
| 29.7508% | |
| 30.1491% | |
| 10.0618% | |
| 27.1965% | |
| 52.2027% | |
| 61.2518% | |
| 36.755% | |
| 47.4958% | |
| 0.6342% | |
| 17.5749% | |
| -224.5155% | |
| -94.2798% | |
| -62.4616% | |
| -7.7047% |